Literature DB >> 18563061

Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette.

Arthur L Brody1, Mark A Mandelkern, Richard E Olmstead, Zoe Allen-Martinez, David Scheibal, Anna L Abrams, Matthew R Costello, Judah Farahi, Sanjaya Saxena, John Monterosso, Edythe D London.   

Abstract

Prior studies have demonstrated that both nicotine administration and cigarette smoking lead to dopamine (DA) release in the ventral striatum/nucleus accumbens. In tobacco-dependent individuals, smoking denicotinized cigarettes leads to reduced craving, but less pleasure, than smoking regular cigarettes. Using denicotinized cigarettes and (11)C-raclopride positron emission tomography (PET) scanning, we sought to determine if nicotine is necessary for smoking-induced DA release. Sixty-two tobacco-dependent smokers underwent (11)C-raclopride PET scanning, during which they smoked either a regular or denicotinized cigarette (double-blind). Change in (11)C-raclopride binding potential (BP) in the ventral striatum from before to after smoking was determined as an indirect measure of DA release. Cigarette craving, anxiety, and mood were monitored during scanning. Smoking a regular cigarette resulted in a significantly greater mean reduction in ventral striatal (11)C-raclopride BP than smoking a denicotinized cigarette. Although both groups had reductions in craving and anxiety with smoking, the regular cigarette group had a greater improvement in mood. For the total group, change in BP correlated inversely with change in mood, indicating that greater smoking-induced DA release was associated with more smoking-related mood improvement. Thus, nicotine delivered through cigarette smoking appears to be important for ventral striatal DA release. Study findings also suggest that mood improvement from smoking is specifically related to ventral striatal DA release.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18563061      PMCID: PMC2777990          DOI: 10.1038/npp.2008.87

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  78 in total

1.  Brain metabolic changes during cigarette craving.

Authors:  Arthur L Brody; Mark A Mandelkern; Edythe D London; Anna Rose Childress; Grace S Lee; Robert G Bota; Matthew L Ho; Sanjaya Saxena; Lewis R Baxter; Damian Madsen; Murray E Jarvik
Journal:  Arch Gen Psychiatry       Date:  2002-12

2.  Effects of cigarette nicotine content and smoking pace on subsequent craving and smoking.

Authors:  Jesse Dallery; Elisabeth J Houtsmuller; Wallace B Pickworth; Maxine L Stitzer
Journal:  Psychopharmacology (Berl)       Date:  2002-10-31       Impact factor: 4.530

3.  Effects of catecholamine depletion on D2 receptor binding, mood, and attentiveness in humans: a replication study.

Authors:  Nicolaas P L G Verhoeff; Bruce K Christensen; Doug Hussey; Maggie Lee; George Papatheodorou; Lili Kopala; Qing Rui; Robert B Zipursky; Shitij Kapur
Journal:  Pharmacol Biochem Behav       Date:  2003-01       Impact factor: 3.533

4.  Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum.

Authors:  Diana Martinez; Mark Slifstein; Allegra Broft; Osama Mawlawi; Dah-Ren Hwang; Yiyun Huang; Thomas Cooper; Lawrence Kegeles; Eric Zarahn; Anissa Abi-Dargham; Suzanne N Haber; Marc Laruelle
Journal:  J Cereb Blood Flow Metab       Date:  2003-03       Impact factor: 6.200

5.  Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum.

Authors:  O Mawlawi; D Martinez; M Slifstein; A Broft; R Chatterjee; D R Hwang; Y Huang; N Simpson; K Ngo; R Van Heertum; M Laruelle
Journal:  J Cereb Blood Flow Metab       Date:  2001-09       Impact factor: 6.200

6.  Differences in nicotine-induced dopamine release and nicotine pharmacokinetics between Lewis and Fischer 344 rats.

Authors:  M N Lipovac; A Hashim; H Sershen; D Allen; T Cooper; P Czobor; A Lajtha
Journal:  Neurochem Res       Date:  2001-06       Impact factor: 3.996

7.  Comparative effects of methamphetamine and nicotine on the striatal [(11)C]raclopride binding in unanesthetized monkeys.

Authors:  Hideo Tsukada; Katsumasa Miyasato; Takeharu Kakiuchi; Shingo Nishiyama; Norihiro Harada; Edward F Domino
Journal:  Synapse       Date:  2002-09-15       Impact factor: 2.562

8.  In vivo detection of striatal dopamine release during reward: a PET study with [(11)C]raclopride and a single dynamic scan approach.

Authors:  S Pappata; S Dehaene; J B Poline; M C Gregoire; A Jobert; J Delforge; V Frouin; M Bottlaender; F Dolle; L Di Giamberardino; A Syrota
Journal:  Neuroimage       Date:  2002-08       Impact factor: 6.556

9.  PET studies of the influences of nicotine on neural systems in cigarette smokers.

Authors:  Jed E Rose; Frederique M Behm; Eric C Westman; Roy J Mathew; Edythe D London; Thomas C Hawk; Timothy G Turkington; R Edward Coleman
Journal:  Am J Psychiatry       Date:  2003-02       Impact factor: 18.112

10.  Effects of amphetamine and evoked dopamine release on [11C]raclopride binding in anesthetized cats.

Authors:  Nathalie Ginovart; Wadad Hassoun; Marion Le Cavorsin; Laurent Veyre; Didier Le Bars; Vincent Leviel
Journal:  Neuropsychopharmacology       Date:  2002-07       Impact factor: 7.853

View more
  53 in total

1.  Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats.

Authors:  Amir H Rezvani; Susan Slade; Cori Wells; Ann Petro; Lawrence Lumeng; Ting-Kai Li; Yingxian Xiao; Milton L Brown; Mikell A Paige; Brian E McDowell; Jed E Rose; Kenneth J Kellar; Edward D Levin
Journal:  Psychopharmacology (Berl)       Date:  2010-06-10       Impact factor: 4.530

2.  Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [11C]DAA1106 Positron Emission Tomography Study.

Authors:  Arthur L Brody; Robert Hubert; Ryutaro Enoki; Lizette Y Garcia; Michael S Mamoun; Kyoji Okita; Edythe D London; Erika L Nurmi; Lauren C Seaman; Mark A Mandelkern
Journal:  Neuropsychopharmacology       Date:  2017-03-06       Impact factor: 7.853

3.  Sex differences in striatal dopamine release in young adults after oral alcohol challenge: a positron emission tomography imaging study with [¹¹C]raclopride.

Authors:  Nina B L Urban; Lawrence S Kegeles; Mark Slifstein; Xiaoyan Xu; Diana Martinez; Ehab Sakr; Felipe Castillo; Tiffany Moadel; Stephanie S O'Malley; John H Krystal; Anissa Abi-Dargham
Journal:  Biol Psychiatry       Date:  2010-08-03       Impact factor: 13.382

Review 4.  Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction.

Authors:  Johanna M Jarcho; Emeran A Mayer; Ziyue Karen Jiang; Natasha A Feier; Edythe D London
Journal:  Pain       Date:  2012-03-03       Impact factor: 6.961

5.  Neuroimaging in Alcohol and Drug Dependence.

Authors:  Mark J Niciu; Graeme F Mason
Journal:  Curr Behav Neurosci Rep       Date:  2014-03-01

6.  Smoking and Neuroimaging: A Review.

Authors:  Hedy Kober; Cameron M Deleone
Journal:  Curr Cardiovasc Risk Rep       Date:  2011-12-01

7.  Nicotine sensitization (Part 2): Time spent in the centre of an open field sensitizes to repeated nicotine into the drug-free state in female rats.

Authors:  Jennet L Baumbach; Cheryl M McCormick
Journal:  Psychopharmacology (Berl)       Date:  2020-10-29       Impact factor: 4.530

Review 8.  Abuse liability assessment of tobacco products including potential reduced exposure products.

Authors:  Lawrence P Carter; Maxine L Stitzer; Jack E Henningfield; Rich J O'Connor; K Michael Cummings; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

9.  Prolonged exposure to denicotinized cigarettes with or without transdermal nicotine.

Authors:  Eric C Donny; Melissa Jones
Journal:  Drug Alcohol Depend       Date:  2009-05-15       Impact factor: 4.492

10.  Perspective: Translational studies on glutamate and dopamine neurocircuitry in addictions: implications for addiction treatment.

Authors:  Evelyn K Lambe; Tony P George
Journal:  Neuropsychopharmacology       Date:  2008-11-05       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.